• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A28-28/C95-O20
Device Problems Failure To Adhere Or Bond (1031); Leak/Splash (1354); Migration or Expulsion of Device (1395); Material Separation (1562); Stretched (1601); Use of Device Problem (1670)
Patient Problems Aneurysm (1708); Death (1802); Failure of Implant (1924); Ischemia (1942); Renal Failure (2041); Rupture (2208); Respiratory Failure (2484)
Event Date 06/07/2018
Event Type  Death  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with an afx to treat an abdominal aortic aneurysm.3 years after the original implant a secondary procedure was performed to address a type lllb endoleak.Two years post-secondary procedure a tertiary procedure was performed to address a type la endoleak of the cuff.The physician elected to repair the leak by covering the left renal cuff.The physician stated that he did not identify any loss of integrity in the main body.On (b)(6) 2018, five days post tertiary procedure, the patient expired.The cause of death is unknown at this time.
 
Manufacturer Narrative
Clinical evaluations was able to find substantial evidence to support the following reported events; type ia endoleak (cuff) and death.Clinical was able to find additional evidence that was not reported with the initial reported event.Clinical assessment determined that there was evidence to reasonable suggest stent cage dilation of the cuff (20%) and main body (78%), rupture, sac growth of 24.5 mm and crown separation.These events were discovered during review of the 43 month post implant ct scan.The patient death was determined to be device related.The manufacturing records confirm that the lots met all requirements prior to release.Device remains implanted in the patient and was not returned, no evaluation completed.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.Correction: concomitant medical products and therapy dates - remove 1050592-057.
 
Event Description
Additional information received per clinical assessment confirming that the patient had an off-label neck anatomy at the time of the initial implant.In addition, the following observations were confirmed present at the time of the reported event: acute renal failure, lower leg ischemia, acute respiratory failure, rupture, aneurysm sac growth by 24.5mm, crown separation, and stent cage dilation of the proximal extension (20%) and bifurcated device (78%).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key7648862
MDR Text Key112692357
Report Number2031527-2018-00574
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 06/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2016
Device Model NumberA28-28/C95-O20
Device Catalogue NumberF00553
Device Lot Number1050592-057
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/07/2018
Initial Date FDA Received06/28/2018
Supplement Dates Manufacturer Received06/07/2018
Supplement Dates FDA Received03/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT, LOT 1053281-014; LIMB STENT GRAFT, LOT 1039909-017; SUPRARENAL AORTIC EXTENSION, LOT 1050592-057
Patient Outcome(s) Death; Required Intervention;
Patient Age76 YR
-
-